Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 3 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Researchers say AI blood test provides a reliable way to identify lung cancer
Medical Xpress· 2 days agoVelculescu, M.D., Ph.D., professor of oncology and co-director of the Cancer Genetics and Epigenetics program at the Johns Hopkins Kimmel Cancer ...
Study claims rich people at greater risk of getting cancer | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoWealthy people are at greater risk of cancer than the less well-off, suggests new research. Study...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 5 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
'Disturbing' surge in young cancers may be linked to gut health, say experts
Daily Express· 6 days agoUnhealthy lifestyles, an obesity epidemic and poor gut health are feared to be fuelling a...
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 3 days agos an alarming trend we are seeing," Sivendran said. "Colorectal cancer was previously the fourth...
Rich people have 'greater cancer risk' than poor, study finds
Yahoo Life UK· 6 days agoA separate study from 2006 found that cancer was more likely in children from affluent backgrounds...
Wealthy people ‘at greater risk of cancer’ than the rest of us: study
NY Post via Yahoo News· 7 days agoStudy leader Dr Fiona Hagenbeek, of the university’s Institute for... (FIMM), said the initial...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 7 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 3 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...